DeepMed Research

Alliance for Clinical Trials in Oncology

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 2011-01-01

Employees: 251

Market Cap: -

Website: https://www.allianceforclinicaltrialsinoncology.org

Clinical Trials

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

Phase 2

Completed

Conditions: Leukemia
Lymphoma

Interventions: Drug: cyclophosphamide
Drug: cytarabine
Drug: dexamethasone
Drug: doxorubicin hydrochloride
Drug: etoposide
Drug: ifosfamide
Drug: leucovorin calcium
Drug: mesna
Drug: methotrexate
Drug: prednisone
Drug: therapeutic hydrocortisone
Drug: vincristine sulfate
Radiation: low-LET cobalt-60 gamma ray therapy
Radiation: low-LET photon therapy

First Posted Date: 2004-04-06

Last Posted Date: 2016-07-04

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 134

Registration Number: NCT00002494

Locations: 🇺🇸
Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States
🇺🇸
University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States
🇺🇸
Ellis Fischel Cancer Center - Columbia, Columbia, Missouri, United States

and more 20 locations

Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach

Phase 1

Completed

Conditions: Gastric Cancer
Pancreatic Cancer

Interventions: Drug: cisplatin
Drug: gemcitabine hydrochloride
Radiation: radiation therapy

First Posted Date: 2004-03-30

Last Posted Date: 2016-07-14

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 26

Registration Number: NCT00003157

Locations: 🇺🇸
Siouxland Hematology-Oncology, Sioux City, Iowa, United States
🇺🇸
CentraCare Clinic, Saint Cloud, Minnesota, United States
🇺🇸
CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States

and more 15 locations

Ceramide Cream in Treating Women With Cutaneous Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: ceramide

First Posted Date: 2004-03-25

Last Posted Date: 2016-12-06

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 26

Registration Number: NCT00008320

Locations: 🇺🇸
CCOP - Carle Cancer Center, Urbana, Illinois, United States
🇺🇸
Siouxland Hematology-Oncology, Sioux City, Iowa, United States
🇺🇸
Medcenter One Health System, Bismarck, North Dakota, United States

and more 10 locations

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

Phase 3

Completed

Conditions: Lymphoma
Unspecified Childhood Solid Tumor, Protocol Specific
Chronic Myeloproliferative Disorders
Nausea and Vomiting
Precancerous Condition
Myelodysplastic Syndromes
Leukemia
Multiple Myeloma and Plasma Cell Neoplasm
Small Intestine Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Drug: ondansetron
Other: placebo

First Posted Date: 2004-03-25

Last Posted Date: 2016-07-06

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 100

Registration Number: NCT00006348

Locations: 🇺🇸
CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States
🇺🇸
Rapid City Regional Hospital, Rapid City, South Dakota, United States
🇺🇸
Altru Health Systems, Grand Forks, North Dakota, United States

and more 9 locations

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: gemcitabine hydrochloride
Drug: irinotecan hydrochloride

First Posted Date: 2004-03-24

Last Posted Date: 2016-07-14

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 73

Registration Number: NCT00005972

Locations: 🇺🇸
Veterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, United States
🇺🇸
University of Chicago Cancer Research Center, Chicago, Illinois, United States
🇺🇸
Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States

and more 47 locations

Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer

Phase 1

Completed

Conditions: Cancer

Interventions: Drug: capecitabine
Radiation: radiation therapy

First Posted Date: 2004-03-15

Last Posted Date: 2016-07-06

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 51

Registration Number: NCT00003704

Locations: 🇺🇸
CentraCare Clinic, Saint Cloud, Minnesota, United States
🇨🇦
Allan Blair Cancer Centre, Regina, Saskatchewan, Canada
🇺🇸
Siouxland Hematology-Oncology, Sioux City, Iowa, United States

and more 15 locations

Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases

Phase 3

Completed

Conditions: Metastatic Cancer
Prostate Cancer

Interventions: Drug: zoledronic acid
Other: placebo
Drug: androgen deprivation therapy
Drug: GnRH agonist
Dietary Supplement: Calcium supplement
Dietary Supplement: Vitamin D

First Posted Date: 2004-03-09

Last Posted Date: 2020-05-12

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 645

Registration Number: NCT00079001

Locations: 🇺🇸
Good Samaritan Hospital of Maryland, Baltimore, Maryland, United States
🇺🇸
Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States
🇺🇸
Fisher-Titus Medical Center, Norwalk, Ohio, United States

and more 237 locations

Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: docetaxel
Drug: irinotecan hydrochloride

First Posted Date: 2004-03-09

Last Posted Date: 2016-12-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 70

Registration Number: NCT00079118

Locations: 🇺🇸
Kenton Oncology, Incorporated, Kenton, Ohio, United States
🇺🇸
McDonough District Hospital, Macomb, Illinois, United States
🇺🇸
Hurley Medical Center, Flint, Michigan, United States

and more 156 locations

Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas

Phase 2

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: ISIS 2503
Drug: gemcitabine hydrochloride

First Posted Date: 2004-03-08

Last Posted Date: 2016-07-06

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 48

Registration Number: NCT00006467

Locations: 🇺🇸
CCOP - Carle Cancer Center, Urbana, Illinois, United States
🇺🇸
Siouxland Hematology-Oncology, Sioux City, Iowa, United States
🇺🇸
CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States

and more 13 locations

Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach

Phase 2

Completed

Conditions: Gastric Cancer
Esophageal Cancer

Interventions: Drug: docetaxel
Drug: irinotecan hydrochloride

First Posted Date: 2004-03-03

Last Posted Date: 2016-07-14

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 47

Registration Number: NCT00004235

Locations: 🇺🇸
CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States
🇺🇸
Medcenter One Health System, Bismarck, North Dakota, United States
🇺🇸
CCOP - Geisinger Clinic and Medical Center, Danville, Pennsylvania, United States

and more 16 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy